# Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics

> **NCT00668395** · NA · COMPLETED · sponsor: **Indiana University** · enrollment: 73 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT00668395
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2014-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668395, "Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00668395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*